Stockreport

ImmunityBio's Anktiva Could See More Upside: My Updated Thoughts On Expansion [Seeking Alpha]

ImmunityBio, Inc.  (IBRX) 
PDF IBRX's EU commercial rollout via Accord Healthcare and new Dublin subsidiary rapidly expands Anktiva's addressable market and validates its global immunotherapy potenti [Read more]